Attached files
| file | filename |
|---|---|
| 8-K - Cantabio Pharmaceuticals Inc. | form8-k.htm |
EXHIBIT 16.1
February 23, 2016
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, DC 20549
We have read the statements of Cantabio Pharmaceuticals, Inc., pertaining to our firm included under Item 4.01 of Form 8-K dated February 23, 2016 and agree with such statements as they pertain to our firm.
Sincerely,
/s/ KLJ & Associates, LLP